女性不妊・妊娠迅速検査市場：デバイスタイプ、検査タイプ、タイプ、流通チャネル別-2025-2030年世界予測

女性不妊・妊娠迅速検査市場は、2023年に19億5,000万米ドルと評価され、2024年には21億米ドルに達すると予想され、CAGR 7.72％で成長し、2030年には32億9,000万米ドルになると予測されています。

女性の不妊・妊娠迅速検査市場には、不妊や妊娠に関連する特定のホルモンを検出するように設計された幅広い診断製品が含まれます。これらの検査は、女性に生殖状態に関するタイムリーで正確な情報を提供し、それによって家族計画やヘルスケアの意思決定を支援するために不可欠です。これらの検査は、臨床、家庭、小売の場で広く使用されており、利便性とプライバシーを提供しています。市場の必要性は、女性の健康と生殖計画に対する意識の高まりと、市販の診断ソリューションに対する需要の高まりに起因しています。最終用途の範囲には、病院、診断センター、在宅ケア環境が含まれ、これらのツールの多用途性と広範な用途を反映しています。

成長に影響を与える主な要因としては、診断技術の進歩、ヘルスケア支出の増加、ライフスタイルの変化や妊娠の遅れなどの要因による不妊症や妊娠関連合併症の発生率の増加などが挙げられます。市場拡大のチャンスは、ヘルスケアインフラが整備された新興国や、デジタル検査やスマートフォン一体型検査などの製品イノベーションにあります。企業は、使いやすさと手頃な価格に重点を置くことで、こうした機会を活用し、消費者の満足度を高め、市場リーチを拡大することができます。

しかし、厳しい規制要件、検査結果の不正確さ、特定の地域における文化的障壁など、市場浸透を制限しかねない課題に直面しています。技術革新の面では、より高感度で特異的な検査の開発、予測分析強化のためのAIの活用の模索、結果追跡のためのデータ管理システムの統合などに大きな機会があります。

女性の不妊・妊娠迅速検査市場はダイナミックであり、個別化ヘルスケアソリューションへのシフトが進んでいます。最適な事業成長のためには、企業はヘルスケアプロバイダーやテクノロジー企業との提携に注力し、デジタルヘルスの動向を活用する一方、規制状況を効果的にナビゲートして新製品を迅速かつコンプライアンスに従って導入する必要があります。

市場力学：急速に進化する女性不妊・妊娠迅速検査市場の主要市場インサイトを公開

女性不妊・妊娠迅速検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 時間のかかるラボベースの検査よりも、迅速で自己完結型の検査に対する需要の高まり
  • 不妊症や婦人科疾患の罹患率の増加
• 市場抑制要因
  • 選択肢が多すぎることによる選択の不条理
  • 論争や機器関連の問題
• 市場機会
  • スマートフォンアプリとの連携など、技術の進歩と魅力的な製品機能
  • 新興経済諸国におけるキットの認知度向上
• 市場の課題
  • 血液検査や試薬ベースのラボ検査など、エラーの可能性が低い代替診断検査の利用可能性

ポーターの5つの力：女性不妊・妊娠迅速検査市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：女性不妊・妊娠迅速検査市場における外部からの影響の把握

外部マクロ環境要因は、女性不妊・妊娠迅速検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析女性不妊・妊娠迅速検査市場における競合情勢の把握

女性不妊・妊娠迅速検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス女性不妊・妊娠迅速検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、女性不妊・妊娠迅速検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨女性不妊・妊娠迅速検査市場における成功への道筋を描く

女性不妊・妊娠迅速検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 時間のかかるラボベースのテストよりも、迅速で自己完結型のテストに対する需要が高まっている
    • 不妊症や婦人科疾患の増加
  • 抑制要因
    • 選択肢が多すぎることによる選択の不合理
    • 論争とデバイス関連の問題
  • 機会
    • スマートフォンアプリとの連携など、技術の進歩と魅力的な製品機能
    • 新興経済諸国におけるキットに関する認知度の向上
  • 課題
    • 血液検査や試薬ベースの臨床検査など、エラーの可能性が低い代替診断検査の利用可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 女性不妊・妊娠迅速検査市場デバイスタイプ別

• デジタルデバイス
• ラインインジケータデバイス

第7章 女性不妊・妊娠迅速検査市場テストタイプ別

• FSH尿検査
• HCG血液検査
• HCG尿検査
• LH尿検査

第8章 女性不妊・妊娠迅速検査市場：タイプ別

• 不妊治療迅速検査キット
• 妊娠迅速検査キット

第9章 女性不妊・妊娠迅速検査市場：流通チャネル別

• ドラッグストア
• 婦人科・不妊治療クリニック
• ハイパーマーケットとスーパーマーケット
• オンライン
• 薬局

第10章 南北アメリカの女性不妊・妊娠迅速検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の女性不妊・妊娠迅速検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの女性不妊・妊娠迅速検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Atlas Medical GmbH
• bioMerieux SA
• Church & Dwight Co., Inc.
• EGENS GROUP
• Eurofins Scientific
• Everly Health, Inc.
• Expedient Healthcare Marketing Private Limited
• Genea Limited
• Geratherm Medical AG
• Novartis AG
• OneCare Media
• Prestige Consumer Healthcare Inc.
• Progyny, Inc.
• Quidel Corporation
• Thermo Fisher Scientific

LIST OF FIGURES

• FIGURE 1. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET RESEARCH PROCESS
• FIGURE 2. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET DYNAMICS
• TABLE 7. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DIGITAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY LINE-INDICATOR DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY FSH URINE TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY HCG BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY HCG URINE TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY LH URINE TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY FERTILITY RAPID TEST KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY PREGNANCY RAPID TEST KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DRUGSTORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY GYNECOLOGY & FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY HYPERMARKETS & SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 37. CANADA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 39. CANADA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. CANADA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. CHINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 60. CHINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CHINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. CHINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 63. INDIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. INDIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. INDIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 132. ITALY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 133. ITALY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ITALY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. ITALY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 148. POLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. POLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 150. POLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. POLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 152. QATAR FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 153. QATAR FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 154. QATAR FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. QATAR FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 192. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 193. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET, FPNV POSITIONING MATRIX, 2023

The Female Fertility & Pregnancy Rapid Test Market was valued at USD 1.95 billion in 2023, expected to reach USD 2.10 billion in 2024, and is projected to grow at a CAGR of 7.72%, to USD 3.29 billion by 2030.

The female fertility and pregnancy rapid test market involves a broad spectrum of diagnostic products designed to detect specific hormones associated with fertility and pregnancy. These tests are essential for providing women with timely and accurate information about their reproductive status, thereby supporting family planning and healthcare decision-making. They are widely used in clinical, home, and retail settings, offering convenience and privacy. The market's necessity stems from the increasing awareness of health and reproductive planning among women, as well as the rising demand for over-the-counter diagnostic solutions. End-use scopes include hospitals, diagnostic centers, and home-care environments, reflecting the versatility and widespread application of these tools.

Key influencing growth factors include advancements in diagnostic technology, increased healthcare expenditure, and a higher incidence of infertility and pregnancy-related complications, driven by factors such as lifestyle changes and delayed pregnancies. Opportunities for market expansion lie in emerging economies with improving healthcare infrastructures, as well as through product innovations like digital and smartphone-integrated tests. Companies can capitalize on these opportunities by focusing on user-friendliness and affordability, which can enhance consumer satisfaction and expand market reach.

However, the market faces challenges like strict regulatory requirements, occasional inaccuracies in test results, and cultural barriers in certain regions which may limit market penetration. In terms of innovation, there are significant opportunities in developing more sensitive and specific tests, exploring the use of AI for enhanced predictive analytics, and integrating data management systems for result tracking.

The female fertility and pregnancy rapid test market is dynamic, with a favorable shift towards personalized healthcare solutions. For optimal business growth, companies should focus on partnerships with healthcare providers and technology firms to leverage digital health trends, whilst navigating regulatory landscapes effectively to introduce new products swiftly and compliantly.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Female Fertility & Pregnancy Rapid Test Market

The Female Fertility & Pregnancy Rapid Test Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising demand for the quick and self-contained test than the time-consuming lab-based test
  • Growing incidence of infertility and gynecological disorders
• Market Restraints
  • Absurdity of choice due to the availability of too many options
  • Controversies and device-related issues
• Market Opportunities
  • Technological advancements and attractive product features such as smartphone app connectivity
  • Increasing awareness about the kits in the developing economies
• Market Challenges
  • Availability of alternative diagnostic tests, such as blood test and reagent-based laboratory test with fewer chances of error

Porter's Five Forces: A Strategic Tool for Navigating the Female Fertility & Pregnancy Rapid Test Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Female Fertility & Pregnancy Rapid Test Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Female Fertility & Pregnancy Rapid Test Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Female Fertility & Pregnancy Rapid Test Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Female Fertility & Pregnancy Rapid Test Market

A detailed market share analysis in the Female Fertility & Pregnancy Rapid Test Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Female Fertility & Pregnancy Rapid Test Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Female Fertility & Pregnancy Rapid Test Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Female Fertility & Pregnancy Rapid Test Market

A strategic analysis of the Female Fertility & Pregnancy Rapid Test Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Female Fertility & Pregnancy Rapid Test Market, highlighting leading vendors and their innovative profiles. These include Atlas Medical GmbH, bioMerieux SA, Church & Dwight Co., Inc., EGENS GROUP, Eurofins Scientific, Everly Health, Inc., Expedient Healthcare Marketing Private Limited, Genea Limited, Geratherm Medical AG, Novartis AG, OneCare Media, Prestige Consumer Healthcare Inc., Progyny, Inc., Quidel Corporation, and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the Female Fertility & Pregnancy Rapid Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Device Type, market is studied across Digital Devices and Line-Indicator Devices.
• Based on Test Type, market is studied across FSH Urine Test, HCG Blood Test, HCG Urine Test, and LH Urine Test.
• Based on Type, market is studied across Fertility Rapid Test Kits and Pregnancy Rapid Test Kits.
• Based on Distribution Channel, market is studied across Drugstores, Gynecology & Fertility Clinics, Hypermarkets & Supermarkets, Online, and Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising demand for the quick and self-contained test than the time-consuming lab-based test
    • 5.1.1.2. Growing incidence of infertility and gynecological disorders
  • 5.1.2. Restraints
    • 5.1.2.1. Absurdity of choice due to the availability of too many options
    • 5.1.2.2. Controversies and device-related issues
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements and attractive product features such as smartphone app connectivity
    • 5.1.3.2. Increasing awareness about the kits in the developing economies
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative diagnostic tests, such as blood test and reagent-based laboratory test with fewer chances of error
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Female Fertility & Pregnancy Rapid Test Market, by Device Type

• 6.1. Introduction
• 6.2. Digital Devices
• 6.3. Line-Indicator Devices

7. Female Fertility & Pregnancy Rapid Test Market, by Test Type

• 7.1. Introduction
• 7.2. FSH Urine Test
• 7.3. HCG Blood Test
• 7.4. HCG Urine Test
• 7.5. LH Urine Test

8. Female Fertility & Pregnancy Rapid Test Market, by Type

• 8.1. Introduction
• 8.2. Fertility Rapid Test Kits
• 8.3. Pregnancy Rapid Test Kits

9. Female Fertility & Pregnancy Rapid Test Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Drugstores
• 9.3. Gynecology & Fertility Clinics
• 9.4. Hypermarkets & Supermarkets
• 9.5. Online
• 9.6. Pharmacies

10. Americas Female Fertility & Pregnancy Rapid Test Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Female Fertility & Pregnancy Rapid Test Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Female Fertility & Pregnancy Rapid Test Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Atlas Medical GmbH
• 2. bioMerieux SA
• 3. Church & Dwight Co., Inc.
• 4. EGENS GROUP
• 5. Eurofins Scientific
• 6. Everly Health, Inc.
• 7. Expedient Healthcare Marketing Private Limited
• 8. Genea Limited
• 9. Geratherm Medical AG
• 10. Novartis AG
• 11. OneCare Media
• 12. Prestige Consumer Healthcare Inc.
• 13. Progyny, Inc.
• 14. Quidel Corporation
• 15. Thermo Fisher Scientific